Evidence map›Paper›PMID 40688711›Full record

ArticleRespiratory medicine case reports2025

Case of a rare EGFR mutation L

Hitoshi Sumitani, Akihiro Tamiya, Yuki Iwahashi, Daisuke Sekinada, Akihiro Tsukaguchi, Yuya Tanaka, Takafumi Iguchi, Yuji Inagaki, Yoshihiko Taniguchi, Tomoko Kagawa and 2 more

Abstract readCase Reports
In one paragraph

Article in Respiratory medicine case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hitoshi SumitaniDepartments of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Akihiro TamiyaDepartments of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Yuki IwahashiDepartments of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Daisuke SekinadaDepartments of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Akihiro TsukaguchiDepartments of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Yuya TanakaDepartments of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Takafumi IguchiDepartments of Respiratory Surgery, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Yuji InagakiDepartments of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Yoshihiko TaniguchiDepartments of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Tomoko KagawaDepartments of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Yoshinobu MatsudaPsychosomatic Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.
Kyoichi OkishioDepartments of Internal Medicine, NHO Kinki Chuo Chest Medical Center, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report describes the case of a 44-year-old Japanese female diagnosed with Stage IA lung adenocarcinoma harboring a rare epidermal growth factor receptor (

Indexed as

AfatinibCompact panelL747PLung adenocarcinomaRare EGFR mutation

Identifiers

PMID40688711
PMCPMC12272770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.